Drugs Made In America Acquisition II Corp. (DMII) Financial Statements
Drugs Made In America Acquisition II Corp. (DMII) files with the U.S. Securities and Exchange Commission under CIK 0002040475. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2025
- Net Income (Loss)
- $4.19 million
- Total Assets
- $504.96 million
- Net Cash from Operations
- -$1.02 million
Fiscal year ended Dec 31, 2025. Latest periodic SEC filing: Aug 14, 2026. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for DMII in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History